BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 31477034)

  • 1. Evaluation of the association of Wnt signaling with coronary artery calcification in patients on dialysis with severe secondary hyperparathyroidism.
    Ho TY; Chen NC; Hsu CY; Huang CW; Lee PT; Chou KJ; Fang HC; Chen CL
    BMC Nephrol; 2019 Sep; 20(1):345. PubMed ID: 31477034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the role of severe hyperparathyroidism on coronary artery calcification in dialysis patients.
    Hernandes FR; Barreto FC; Rocha LA; Draibe SA; Canziani ME; Carvalho AB
    Clin Nephrol; 2007 Feb; 67(2):89-95. PubMed ID: 17338428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abdominal aortic calcification score among several vascular calcification scores of plain radiograph is the most reliable predictor of severe coronary artery calcification in dialysis patients.
    Lee SM; Lee HW; Son YK; Kim SE; An WS
    Ren Fail; 2017 Nov; 39(1):729-735. PubMed ID: 29157086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients.
    Chen Z; Qureshi AR; Ripsweden J; Wennberg L; Heimburger O; Lindholm B; Barany P; Haarhaus M; Brismar TB; Stenvinkel P
    Bone; 2016 Nov; 92():50-57. PubMed ID: 27519971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between coronary artery calcification and bone metabolic markers in maintenance hemodialysis patients.
    Xiong L; Chen QQ; Cheng Y; Lan YS; Yang JB; Wen XQ; Xie X; Kang T; Wu WH; Ou S
    BMC Nephrol; 2023 Aug; 24(1):238. PubMed ID: 37582785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance Dialysis.
    Zhang H; Li G; Yu X; Yang J; Jiang A; Cheng H; Fu J; Liang X; Liu J; Lou J; Wang M; Xing C; Zhang A; Zhang M; Xiao X; Yu C; Wang R; Wang L; Chen Y; Guan T; Peng A; Chen N; Hao C; Liu B; Wang S; Shen D; Jia Z; Liu Z;
    JAMA Netw Open; 2023 May; 6(5):e2310909. PubMed ID: 37126347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of denosumab on cardiovascular calcification in patients with secondary hyperparathyroidism undergoing dialysis: a pilot study.
    Chen CL; Chen NC; Wu FZ; Wu MT
    Osteoporos Int; 2020 Aug; 31(8):1507-1516. PubMed ID: 32246167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of coronary artery calcification and its association with cardiovascular events in patients with chronic kidney disease.
    Wang XR; Yuan L; Shi R; Li H; Wang DG; Wu YG
    Ren Fail; 2021 Dec; 43(1):1172-1179. PubMed ID: 34315328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in bone mineral density after total parathyroidectomy without autotransplantation in the end-stage renal disease patients with secondary hyperparathyroidism.
    Fang L; Wu J; Luo J; Wen P; Xiong M; Cao J; Chen X; Yang J
    BMC Nephrol; 2018 Jun; 19(1):142. PubMed ID: 29907149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.
    Jovanovich A; Isakova T; Block G; Stubbs J; Smits G; Chonchol M; Miyazaki M
    Am J Kidney Dis; 2018 Jan; 71(1):27-34. PubMed ID: 28801122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.
    Malluche HH; Blomquist G; Monier-Faugere MC; Cantor TL; Davenport DL
    J Am Soc Nephrol; 2015 Oct; 26(10):2534-44. PubMed ID: 25838468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
    Morena M; Jaussent I; Dupuy AM; Bargnoux AS; Kuster N; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2015 Aug; 30(8):1345-56. PubMed ID: 25854266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
    Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
    Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients.
    Chen Z; Qureshi AR; Brismar TB; Ripsweden J; Haarhaus M; Barany P; Heimburger O; Lindholm B; Stenvinkel P
    BMC Nephrol; 2019 Feb; 20(1):59. PubMed ID: 30777028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Serum Sclerostin Level, Coronary Artery Calcification, and Patient Outcomes in Maintenance Dialysis Patients.
    Ge Y; Wu B; Yu X; Wang N; Xu X; Zeng M; Zhang B; Mao H; Xing C
    Blood Purif; 2022; 51(3):260-269. PubMed ID: 34161949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular calcification progression and its association with mineral and bone disorder in kidney transplant recipients.
    Sun L; Huang Z; Fei S; Ni B; Wang Z; Chen H; Tao J; Han Z; Ju X; Gu M; Tan R
    Ren Fail; 2023; 45(2):2276382. PubMed ID: 37936391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Wnt/β-catenin signalling inhibitors and uraemic vascular calcifications.
    Yang CY; Chang ZF; Chau YP; Chen A; Yang WC; Yang AH; Lee OK
    Nephrol Dial Transplant; 2015 Aug; 30(8):1356-63. PubMed ID: 25817223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive nomogram model for severe coronary artery calcification in end-stage kidney disease patients.
    Tang X; Qian H; Lu S; Huang H; Wang J; Li F; Bian A; Ye X; Yang G; Ma K; Xing C; Xu Y; Zeng M; Wang N
    Ren Fail; 2024 Dec; 46(2):2365393. PubMed ID: 38874139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors for coronary artery calcification in patients with end-stage renal disease].
    Cui L; Xu J; Bai Y; Zhang J
    Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(38):3133-7. PubMed ID: 26814105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denosumab Decreases Epicardial Adipose Tissue Attenuation in Dialysis Patients with Secondary Hyperparathyroidism and Low Bone Mass.
    Chen CL; Liou ES; Wu MT
    Cardiorenal Med; 2024; 14(1):113-122. PubMed ID: 38325352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.